📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Gloucester Pharma

1.1 - Company Overview

Gloucester Pharma Logo

Gloucester Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical development, acquiring clinical-stage oncology drug candidates and advancing them through regulatory approval and commercialization; owned by Celgene. Its first compound, romidepsin, is a late-stage oncology drug candidate.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Gloucester Pharma

Guided Therapeutics Logo

Guided Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Guided Therapeutics company profile →
Medigene Logo

Medigene

HQ: Germany Website
  • Description: Provider of biotechnology solutions for cancer treatment, offering an end-to-end platform for developing TCR-guided therapies—including TCR-T, TCR-T cell engagers, and TCR-natural killer cell therapies—focused on specificity, sensitivity, and safety. Pipeline includes MDG1015 (NY-ESO-1/LAGE-1a, PD1-41BB) and MDG2011 (KRAS G12V, PD1-41BB) for solid tumors, plus 3S TCR technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medigene company profile →
Transgene Logo

Transgene

HQ: France Website
  • Description: Provider of integrated immunotherapies to treat cancers and chronic infectious diseases, covering research, clinical batch manufacturing, and clinical trials. Portfolio includes TG4050 personalized neoantigen cancer vaccine using genetic engineering and AI; TG4001 therapeutic HPV-16 cancer vaccine; BT-001 (anti-CTLA4, GM-CSF) and TG6050 (IL-12, anti-CTLA4) oncolytic viruses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Transgene company profile →
Salmedix Logo

Salmedix

HQ: United States Website
  • Description: Provider of oncology drug development focused on hematologic malignancies (blood cancers). Primary product SDX-105 is marketed by healthcare professionals in Germany for several types of blood cancers; conducts Phase II clinical trials for SDX-105 in the U.S. and Canada.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Salmedix company profile →
Forty Seven Logo

Forty Seven

HQ: United States Website
  • Description: Provider of clinical-stage immuno-oncology therapies targeting cancer immune evasion pathways, based on technology licensed from Stanford University. Lead program 5F9 is a monoclonal antibody against the CD47 receptor, a 'don't eat me' signal that cancer cells commandeer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Forty Seven company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Gloucester Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Gloucester Pharma

2.2 - Growth funds investing in similar companies to Gloucester Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Gloucester Pharma

4.2 - Public trading comparable groups for Gloucester Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Gloucester Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Gloucester Pharma

What does Gloucester Pharma do?

Gloucester Pharma is a provider of biopharmaceutical development, acquiring clinical-stage oncology drug candidates and advancing them through regulatory approval and commercialization; owned by Celgene. Its first compound, romidepsin, is a late-stage oncology drug candidate.

Who are Gloucester Pharma's competitors?

Gloucester Pharma's competitors and similar companies include Guided Therapeutics, Medigene, Transgene, Salmedix, and Forty Seven.

Where is Gloucester Pharma headquartered?

Gloucester Pharma is headquartered in United States.

How many employees does Gloucester Pharma have?

Gloucester Pharma has 1,000 employees 🔒.

When was Gloucester Pharma founded?

Gloucester Pharma was founded in 2010 🔒.

What sector and industry vertical is Gloucester Pharma in?

Gloucester Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Gloucester Pharma

Who are the top strategic acquirers in Gloucester Pharma's sector and industry

Top strategic M&A buyers and acquirers in Gloucester Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Gloucester Pharma?

Top strategic M&A buyers groups and sectors for Gloucester Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Gloucester Pharma's sector and industry vertical

Which are the top PE firms investing in Gloucester Pharma's sector and industry vertical?

Top PE firms investing in Gloucester Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Gloucester Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Gloucester Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Gloucester Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Gloucester Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Gloucester Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Gloucester Pharma?

The key public trading comparables and valuation benchmarks for Gloucester Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Gloucester Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Gloucester Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Gloucester Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Gloucester Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Gloucester Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Gloucester Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Gloucester Pharma